治疗目标和COPD的精准医学:炎症,离子通道,两者,还是没有?
1BZI Pharma LLC, 1500 1st Ave N., Unit 36, Birmingham, AL 35203-1872, USA.
International journal of molecular sciences
|December 23, 2023
概括
慢性阻塞性肺病 (COPD) 新的治疗点正在出现. 基于这些目标的慢性肺炎的新型分类可以改善精准医学和药物发现,用于这种肺病.
科学领域:
- 肺部医学 肺部医学
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 慢性阻塞性肺病 (COPD) 治疗需要扩大治疗选择.
- 肺部生物学方面的进步揭示了COPD的新治疗点.
- 诸如dupilumab这样的生物药物的成功凸显了针对炎症途径的重要性.
研究的目的:
- 审查COPD的既定和新兴药物目标.
- 根据治疗目标提出COPD的新型分类.
- 为了提高精确医学和加快COPD的药物发现.
主要方法:
- 对既定和新兴的COPD药物点的文献综述.
- 基于治疗目标的新型COPD分类的框架开发.
- 对向治疗对COPD子集的潜在影响的分析.
主要成果:
- 确定了关键的治疗点,包括炎症通路,呼吸道重塑,CFTR离子通道和粘膜功能.
- 根据这些目标,提出了基于COPD的新型分类系统.
- 突出了现有药物 (例如,罗米拉斯) 和新药的潜力.
结论:
- 基于目标的COPD分类可以改进精准医学方法.
- 这种分类可能会加速临床试验和临床前药物发现.
- 针对多样化的细胞机制为未来的COPD治疗提供了一个有希望的途径.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
213
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
213
01:20COPD: Pathogenesis and Clinical Features
283
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
283
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:22Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K